Mongolia vs South America: Proportion of the target population who received a 3rd dose of
Mongolia
96.0%
in 2024
South America
77.0%
in 2024
Mongolia rank
16th
South America rank
16th
Proportion of the target population who received a 3rd dose of over time
- Mongolia
- South America
How they compare
Mongolia currently reports 96.0% against 77.0% in South America, a difference of 19.0%.
That makes Mongolia's figure about 1.2 times South America's.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was South America ahead.
Mongolia ranks 16th and South America ranks 16th of 157 countries.
Across the 2 decades both report, Mongolia averaged higher in 1 and South America in 1.
Head to head by decade
| Decade | Mongolia | South America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.3% | 76.0% | 46.7% | South America |
| 2020s | 94.6% | 71.6% | 23.0% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Mongolia or South America?
- Mongolia, at 96.0% against 77.0% in South America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Mongolia and South America?
- 19.0%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and South America?
- 8 years are reported by both, from 2017 to 2024.
- How do Mongolia and South America rank globally for proportion of the target population who received a 3rd dose of?
- Mongolia ranks 16th and South America ranks 16th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.